Ocular Therapeutix, Inc. logo

Ocular Therapeutix, Inc.


Overview | Financials
Company Name Ocular Therapeutix, Inc.
Symbol OCUL
Currency USD
Price 8.13
Market Cap 1,259,247,570
Dividend Yield 0%
52-week-range 1.995 - 11.31
Industry Biotechnology
Sector Healthcare
CEO Mr. Antony Mattessich
Website https://www.ocutx.com

An error occurred while fetching data.

About Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone

Related Stocks

Theratechnologies Inc. logo

Theratechnologies Inc.


1.435 USD

ClearPoint Neuro, Inc. logo

ClearPoint Neuro, Inc.


7.52 USD

4D Molecular Therapeutics, Inc. logo

4D Molecular Therapeutics, Inc.


27.22 USD

Verastem, Inc. logo

Verastem, Inc.


3.36 USD


Numbers are in millions USD

Numbers are in millions USD